Literature DB >> 16020121

Pediatric osteosarcoma: a 35-year experience in Slovenia.

Dimitrij Kuhelj1, Berta Jereb.   

Abstract

The purpose of this study was to review all the children and adolescents treated for osteosarcoma in Slovenia between 1968 and 1997. Seventy-four patients were included in this retrospective study and classified according to the newly devised classification based on clinical and imaging studies. The overall survival rate is 48%. The stage of the disease and the treatment, including chemotherapy, are the only prognostic factors significantly influencing survival. The survival of patients with osteosarcoma has improved with chemotherapy, but new therapeutic strategies should be found for different stages of disease. The authors' newly devised classification based on clinical and imaging studies proved to be adequate.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16020121     DOI: 10.1080/08880010590935257

Source DB:  PubMed          Journal:  Pediatr Hematol Oncol        ISSN: 0888-0018            Impact factor:   1.969


  2 in total

1.  Phage display-derived peptides for osteosarcoma imaging.

Authors:  Xilin Sun; Gang Niu; Yongjun Yan; Min Yang; Kai Chen; Ying Ma; Nicholas Chan; Baozhong Shen; Xiaoyuan Chen
Journal:  Clin Cancer Res       Date:  2010-06-22       Impact factor: 12.531

2.  Genetic polymorphisms of ERCC-1 and ERCC-2 are not prognostic markers in osteosarcoma patients with chemotherapy: A meta-analysis in Chinese population.

Authors:  Dabiao Liu; Xuesong Liu
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.